David Degen
Affiliations: | 2013 | Rutgers University, New Brunswick, New Brunswick, NJ, United States |
Google:
"David Degen"
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Anwar AF, Elbatrawi YM, Degen D, et al. (2024) Total Synthesis of Marformycins A and D. Organic Letters. 26: 10056-10060 |
Anwar AF, Cain CF, Garza MJ, et al. (2023) Stabilizing pseudouridimycin: Synthesis, RNA-polymerase inhibitory activity, and antibacterial activity of dipeptide-modified analogues. Chemmedchem. e202300474 |
Elbatrawi YM, Gerrein T, Anwar A, et al. (2022) Total Synthesis of Pargamicin A. Organic Letters |
Hassan HM, Degen D, Jang KH, et al. (2022) Correction to: Salinamide F, new depsipeptide antibiotic and inhibitor of bacterial RNA polymerase from a marine-derived Streptomyces sp. The Journal of Antibiotics |
Lin W, Mandal S, Degen D, et al. (2019) Structural basis of ECF-σ-factor-dependent transcription initiation. Nature Communications. 10: 710 |
Lin W, Mandal S, Degen D, et al. (2019) Structural basis of ECF-sigma-factor-dependent transcription initiation. Nature Communications. 10: 710-710 |
Lin W, Das K, Degen D, et al. (2018) Structural Basis of Transcription Inhibition by Fidaxomicin (Lipiarmycin A3). Molecular Cell |
Maffioli SI, Zhang Y, Degen D, et al. (2017) Antibacterial Nucleoside-Analog Inhibitor of Bacterial RNA Polymerase. Cell. 169: 1240-1248.e23 |
Lin W, Mandal S, Degen D, et al. (2017) Structural Basis of Mycobacterium tuberculosis Transcription and Transcription Inhibition. Molecular Cell |
Walker SS, Degen D, Nickbarg E, et al. (2017) Affinity Selection-Mass Spectrometry Identifies a Novel Antibacterial RNA Polymerase Inhibitor. Acs Chemical Biology |